MarketPulse

esophageal cancer

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Esophageal Cancer Market Set to Surge 44% by 2030 as Big Pharma Races for Share

Esophageal cancer market projected to grow 44% to $2.37B by 2030 at 9.5% CAGR, with Pfizer, Roche, and Merck dominating through precision oncology and immunotherapy innovations.
BMYCELGrMRKPFENVS+2pharmaceutical innovationmarket growth
BenzingaBenzinga··Prnewswire

Lucid Diagnostics Plans Q4 2025 Earnings Call for March 26

Lucid Diagnostics ($LUCD) schedules Q4 2025 earnings call for March 26, 2026, with CEO and CFO discussing financial results and growth strategy.
LUCDPAVMearnings callcancer prevention